Drug Shortage Report for NALCROM
| Report ID | 274809 |
| Drug Identification Number | 00500895 |
| Brand name | NALCROM |
| Common or Proper name | Nalcrom |
| Company Name | LUPIN PHARMA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | CROMOLYN SODIUM |
| Strength(s) | 100MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | A07EB |
| ATC description | INTESTINALANTIINFLAMMATORY AGENTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2025-12-19 |
| Estimated end date | 2026-01-05 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-12-19 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 550-1111 RUE ST-CHARLES OUEST LONGUEUIL, QUEBEC CANADA J4K 5G4 |
| Company contact information | lupin@lsu3pl.ca (Customer service / Service à la clientèle) |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-12-19 | French | Compare |
| v1 | 2025-12-19 | English | Compare |
Showing 1 to 2 of 2